Siffon PGR 2mg/500mg/15mg Tablet ER
Marketer
I.I.F.A Health Care
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Siffon PGR 2mg/500mg/15mg Tablet ER
Combiflex DM 2mg/500mg/15mg Extended-Release Tablets manage blood glucose in adults with type 2 diabetes. This triple-action medication, used alongside diet and exercise, enhances insulin effectiveness, thus reducing blood sugar. Follow your physician's prescribed dosage and frequency; take with food to minimize digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; never double the dose. High doses can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or nursing individuals require medical consultation before use. Kidney function tests will be performed before treatment initiation. Limit alcohol consumption to lessen the chance of adverse effects.
Primary Ingredients of Siffon PGR 2mg/500mg/15mg Tablet ER
No text was provided to rewrite.
Uses of Siffon PGR 2mg/500mg/15mg Tablet ER
Managing type 2 diabetes
Major Benefits of Siffon PGR 2mg/500mg/15mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or divide it. Siffon PGR 2mg/500mg/15mg Extended-Release tablets should be administered with a meal.
Common Side effects of Siffon PGR 2mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Siffon PGR 2mg/500mg/15mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Siffon PGR 2mg/500mg/15mg Extended-Release tablets should be administered with a meal.
How Siffon PGR 2mg/500mg/15mg Tablet ER works:
Siffon PGR 2mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications employ diverse actions to optimize blood glucose management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Siffon PGR 2mg/500mg/15mg Extended-Release tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Siffon PGR tablets (2mg/500mg/15mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Siffon PGR 2mg/500mg/15mg tablet is likely not safe for use while breastfeeding. Available human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Siffon PGR 2mg/500mg/15mg Tablet ER cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Regular kidney function monitoring is recommended during treatment. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Siffon PGR 2mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. This medication is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Siffon PGR 2mg/500mg/15mg Tablet ER :
Should you forget a Siffon PGR 2mg/500mg/15mg Extended-Release Tablet, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Siffon PGR 2mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently